| Visualization of early engraftment in clinical islet transplantation by positron-emission tomography T Eich, O Eriksson, T Lundgren New England Journal of Medicine 356 (26), 2754-2755, 2007 | 219 | 2007 |
| Positron emission tomography in clinical islet transplantation O Eriksson, T Eich, A Sundin, A Tibell, G Tufveson, H Andersson, ... American Journal of Transplantation 9 (12), 2816-2824, 2009 | 186 | 2009 |
| Transplantation of macroencapsulated human islets within the bioartificial pancreas βAir to patients with type 1 diabetes mellitus PO Carlsson, D Espes, A Sedigh, A Rotem, B Zimerman, H Grinberg, ... American Journal of Transplantation 18 (7), 1735-1744, 2018 | 178 | 2018 |
| Preparation and evaluation of 68Ga-DOTA-hEGF for visualization of EGFR expression in malignant tumors I Velikyan, ÅL Sundberg, Ö Lindhe, AU Höglund, O Eriksson, E Werner, ... Journal of nuclear medicine 46 (11), 1881-1888, 2005 | 166 | 2005 |
| Overeating saturated fat promotes fatty liver and ceramides compared with polyunsaturated fat: a randomized trial F Rosqvist, J Kullberg, M Ståhlman, J Cedernaes, K Heurling, ... The Journal of Clinical Endocrinology & Metabolism 104 (12), 6207-6219, 2019 | 159 | 2019 |
| Positron emission tomography: a real-time tool to quantify early islet engraftment in a preclinical large animal model T Eich, O Eriksson, A Sundin, S Estrada, D Brandhorst, H Brandhorst, ... Transplantation 84 (7), 893-898, 2007 | 127 | 2007 |
| Effects on weight loss and glycemic control with SAR441255, a potent unimolecular peptide GLP-1/GIP/GCG receptor triagonist M Bossart, M Wagner, R Elvert, A Evers, T Hübschle, T Kloeckener, ... Cell metabolism 34 (1), 59-74. e10, 2022 | 109 | 2022 |
| In vivo imaging of the glucagonlike peptide 1 receptor in the pancreas with 68Ga-labeled DO3A-exendin-4 RK Selvaraju, I Velikyan, L Johansson, Z Wu, I Todorov, J Shively, ... Journal of Nuclear Medicine 54 (8), 1458-1463, 2013 | 107 | 2013 |
| Detection of Metastatic Insulinoma by Positron Emission Tomography With [68Ga]Exendin-4—A Case Report O Eriksson, I Velikyan, RK Selvaraju, F Kandeel, L Johansson, G Antoni, ... The Journal of Clinical Endocrinology & Metabolism 99 (5), 1519-1524, 2014 | 96 | 2014 |
| Metformin treatment significantly enhances intestinal glucose uptake in patients with type 2 diabetes: results from a randomized clinical trial JP Koffert, K Mikkola, KA Virtanen, AMD Andersson, L Faxius, K Hällsten, ... diabetes research and clinical practice 131, 208-216, 2017 | 85 | 2017 |
| Positron emission tomography ligand [11C] 5-hydroxy-tryptophan can be used as a surrogate marker for the human endocrine pancreas O Eriksson, D Espes, RK Selvaraju, E Jansson, G Antoni, J Sörensen, ... Diabetes 63 (10), 3428-3437, 2014 | 77 | 2014 |
| In vivo and in vitro characterization of [18F]-FE-(+)-DTBZ as a tracer for beta-cell mass O Eriksson, M Jahan, P Johnström, O Korsgren, A Sundin, C Halldin, ... Nuclear medicine and biology 37 (3), 357-363, 2010 | 77 | 2010 |
| In vivo imaging of beta cells with radiotracers: state of the art, prospects and recommendations for development and use O Eriksson, M Laughlin, M Brom, P Nuutila, M Roden, A Hwa, ... Diabetologia 59, 1340-1349, 2016 | 75 | 2016 |
| Duration and degree of cyclosporin induced P-glycoprotein inhibition in the rat blood–brain barrier can be studied with PET S Syvänen, G Blomquist, M Sprycha, AU Höglund, M Roman, O Eriksson, ... Neuroimage 32 (3), 1134-1141, 2006 | 74 | 2006 |
| Imaging of platelet-derived growth factor receptor β expression in glioblastoma xenografts using affibody molecule 111In-DOTA-Z09591 V Tolmachev, Z Varasteh, H Honarvar, SJ Hosseinimehr, O Eriksson, ... Journal of Nuclear Medicine 55 (2), 294-300, 2014 | 63 | 2014 |
| Gallium-68-labeled affibody molecule for PET imaging of PDGFRβ expression in vivo J Strand, Z Varasteh, O Eriksson, L Abrahmsen, A Orlova, V Tolmachev Molecular pharmaceutics 11 (11), 3957-3964, 2014 | 54 | 2014 |
| Positron emission tomography imaging of the glucagon-like peptide-1 receptor in healthy and streptozotocin-induced diabetic pigs L Nalin, RK Selvaraju, I Velikyan, M Berglund, S Andréasson, A Wikstrand, ... European journal of nuclear medicine and molecular imaging 41, 1800-1810, 2014 | 54 | 2014 |
| Effects of 6 weeks of treatment with dapagliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, on myocardial function and metabolism in patients with type 2 diabetes: a … J Oldgren, S Laurila, A Åkerblom, A Latva‐Rasku, E Rebelos, H Isackson, ... Diabetes, Obesity and Metabolism 23 (7), 1505-1517, 2021 | 52 | 2021 |
| Heterogeneity of metabolic defects in type 2 diabetes and its relation to reactive oxygen species and alterations in beta-cell mass A Elksnis, M Martinell, O Eriksson, D Espes Frontiers in physiology 10, 107, 2019 | 48 | 2019 |
| Cannabinoid type 1 receptors are upregulated during acute activation of brown adipose tissue M Lahesmaa, O Eriksson, T Gnad, V Oikonen, M Bucci, J Hirvonen, ... Diabetes 67 (7), 1226-1236, 2018 | 48 | 2018 |
Lars JohanssonUppsalaVerified email at radiol.uu.se
